Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
166.00
-2.35 (-1.40%)
Oct 12, 2026, 4:00 PM EDT - Market closed
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $8.7 billion as of October 12, 2026. It is the 2,402nd most valuable company in the world and the 832nd biggest in the United States. Its market cap has increased by 43.17% in one year.
Market Cap
8.70B
Enterprise Value
8.60B
1-Year Change
43.17%
Global Rank
Country Rank
#832 United States
Category
ChartMarket Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $8.70B, an increase of 5,513.44%. That is a compound annual growth rate of 44.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 8.70B | -5.56% |
| Dec 31, 2025 | 9.21B | 124.55% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
| Nov 19, 2015 | 154.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Twist Bioscience | 10.02B |
| Krystal Biotech | 9.82B |
| Kymera Therapeutics | 9.35B |
| Protagonist Therapeutics | 9.30B |
| Arrowhead Pharmaceuticals | 8.86B |
| Cytokinetics | 8.75B |
| Caris Life Sciences | 8.39B |
| Spyre Therapeutics | 8.01B |